CD4 and myasthenia gravis: Myasthenia gravis (MG) is a CD4+ T cell-dependent antibody-mediated autoimmune disease, which leads to destruction of the skeletal muscle nicotinic acetylcholine receptor (AChR) at the neuromuscular junction (1, 2) resulting in the hallmark MG symptoms of muscle weakness and fatigue.